Elizabeth Rhea, United States of America

University of Washington Medicine
I am a basic science Research Assistant Professor at the University of Washington and VA Puget Sound in Seattle, WA, USA. I am interested in the impact of insulin signaling in the brain, particularly during aging and in Alzheimer's disease. This interest has led me to my current work on insulin delivery to the CNS, whether by the endogenous route across the blood-brain barrier (BBB) or following intranasal delivery. Insulin transport across the BBB can vary based on physiological or disease state. Therefore, understanding the basic mechanism of how it is transported here could lead to improvements in conditions where transport is deficient. In my free time, I like to get outdoors and explore the beautiful Pacific Northwest, garden, and cook.

Presenter of 2 Presentations

IMPACT OF APOE ISOFORM, SEX, AND DIET ON INSULIN TRANSPORT INTO THE MOUSE CNS

Session Type
SYMPOSIUM
Date
14.03.2021, Sunday
Session Time
08:00 - 10:00
Room
On Demand Symposia B
Lecture Time
09:15 - 09:30
Session Icon
On-Demand

Abstract

Aims

The effects of central nervous system (CNS) insulin on cognition and metabolism are modified by apolipoprotein E (apoE) isoform, sex, and dietary lipids (e.g, a high-fat diet (HFD)). In humans, there are three major apoE isoforms, E2, E3, and E4. Compared to E3, E4 is the major genetic risk factor for the onset of Alzheimer’s disease (AD). Insulin in the CNS is primarily derived from blood insulin, which is transported across the blood-brain barrier (BBB). An alternative way to increase brain insulin levels is by delivering insulin via the intranasal (INL) route, bypassing the BBB and limiting the glucose regulatory effects of insulin. Mild cognitive impairment (MCI) and AD female and male patients with E4 and female patients without E4 respond less well to INL insulin, suggesting an exaggerated deficiency in insulin’s action. Our studies show how transport of insulin across the BBB or following INL delivery may be altered.

Methods

Using radiolabeled insulin, we measured the pharmacokinetics across the BBB in addition to measuring the distribution following INL delivery in E3 and E4 targeted-replacement mice.

Results

Insulin BBB transport varies regionally and the rate and level of vascular binding varies due to apoE isoform, sex, and diet. Following INL delivery, insulin appears throughout the brain within 5 min and remains elevated up to 60 min later.

Conclusions

These results suggest that these three risk factors for AD (apoE isoform, sex, and diet) play a role in regulating insulin transport into the CNS.

Hide